Nivolumab/relatlimab-associated cutaneous immune-related adverse events in patients treated for advanced melanoma: Supplemental file

Name: Nivolumab/relatlimab-associated cutaneous immune-related adverse events in patients treated for advanced melanoma: Supplemental file
Creator: Harvard Medical School; Massachusetts General Hospital; Massachusetts General Hospital Cancer Center; Brigham and Women's Hospital
Published: 2026-04-09T12:26:48+08:00

Mendeley Data2026-04-09 收录

数据链接：

https://data.mendeley.com/datasets/jvw7f27cch 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary tables I (multivariable analysis of patient characteristics associated with developing cirAEs on nivolumab-relatlimab) and II (choice of therapy for the management of first, second, and third cirAEs)

提供机构：

Harvard Medical School; Massachusetts General Hospital; Massachusetts General Hospital Cancer Center; Brigham and Women's Hospital

Nivolumab/relatlimab-associated cutaneous immune-related adverse events in patients treated for advanced melanoma: Supplemental file

资源简介：

相关数据集